image

Prescriptive Analytics Market Report Scope & Overview:

The Prescriptive analytics market size was valued at USD 7.57 Billion in 2023 and is expected to reach USD 43.14 Billion by 2031 and grow at a CAGR of 24.3% over the forecast period 2024-2031.

Businesses are struggling with an ever-increasing volume of data, exceeding the capabilities of traditional Business Intelligence (BI) tools. Prescriptive analytics offers a solution, leveraging advanced algorithms to not only predict future outcomes but also recommend optimal courses of action. This translates to real-world benefits take, for instance, the retail sector. Major players like Amazon and Walmart are utilizing prescriptive analytics to optimize inventory management, personalized marketing campaigns, and even predict customer churn.

Prescriptive Analytics Market Revenue Analysis

Get more information on Prescriptive analytics Market - Request Sample Report

Governments are recognizing this potential as well. In 2020, the European Commission launched a €7 billion initiative focused on promoting a thriving European AI ecosystem, with a significant emphasis on advanced analytics solutions like prescriptive analytics. This several of business needs, technological advancements, and government support is propelling the Prescriptive Analytics Market to new heights.

MARKET DYNAMICS:

KEY DRIVERS:

  • The industry of AI and machine learning is advancing at a breakneck pace.

  • Because of the rise in cyber-crime, there is a greater demand for crime prediction and prevention.

Traditional security measures often play catch-up, leaving businesses vulnerable. Prescriptive analytics empowers organizations to move beyond reactive defense. By analyzing network traffic, user behavior, and threat intelligence, these tools can predict potential cyberattacks and prescribe the most effective countermeasures. Industry leaders like IBM and Cisco are already offering advanced security solutions powered by prescriptive analytics, helping businesses stay a step ahead of cyber threats. This technology isn't just for giants – even smaller firms are recognizing its value, fueling the market's impressive growth path.

RESTRAINTS:

  • The amount, diversity, velocity fluctuation, and authenticity of big data determine its character, which complicates data management.

  • Because data changes over time and there aren't any effective or efficient methods for retrieving proper data, the dynamic nature of data is predicted to limit expansion.

OPPORTUNITY:

  • Every industry in the business world has been touched by the growing volume of data.

  • Security breaches on the internet are causing alarm among enterprises all across the world, but they are also offering new opportunities.

The data deluge has swept across every industry, transforming how businesses operate. No longer a mere record-keeping exercise, data has become the new gold, demanding sophisticated analysis to unlock its true value. This growth is driven by companies like Amazon and Walmart, who leverage prescriptive analytics to optimize everything from inventory management to targeted marketing campaigns, even predicting customer churn before it happens. This proactive approach translates to significant competitive advantages, making prescriptive analytics a game-changer across industries.

CHALLENGES:

  • Various data models depend on business requirements.

IMPACT OF RUSSIA-UKRAINE WAR:

The Russia-Ukraine war creates uncertainty for the Prescriptive Analytics Market. Disruptions in global supply chains, a key factor for industries like manufacturing and logistics that heavily rely on prescriptive analytics for optimized operations, are expected to cause setbacks. The war's impact on crucial resources like oil and gas is further amplifying this effect. The cost of deploying prescriptive analytics solutions, which can range from $50,000 to millions depending on complexity, is projected to rise due to these factors. Companies may become hesitant to invest in new analytics projects amidst economic volatility. However, the war might also present an unexpected opportunity. The need for businesses to adapt to a rapidly changing landscape could fuel demand for prescriptive analytics solutions that can help companies optimize resource allocation and navigate market fluctuations.

IMPACT OF ECONOMIC SLOWDOWN:

An economic slowdown can negatively impact on the Prescriptive Analytics Market. Reduced business spending is a primary concern. Companies might tighten IT budgets, leading to a potential decline in investments for advanced analytics solutions like prescriptive analytics. This could be particularly impactful for smaller players who may struggle to justify the cost during a downturn. For instance, a 2023 survey revealed that 10% of organizations planned to decrease their spending on analytics due to recessionary fears. However, the impact might not be uniform. Prescriptive analytics, with its focus on optimizing processes and maximizing returns, could be seen as a valuable tool for navigating economic challenges. Larger enterprises with a strong financial footing might even increase their investment in prescriptive analytics to optimize resource allocation and mitigate risks.

MARKET SEGMENTATION ANALYSIS:

On the Basis of Component:

The Prescriptive Analytics Market is divided into two key components: software and services. While services currently hold the larger market share, at around 55% in 2023, software is projected to experience the faster growth rate. This is due to the increasing affordability and user-friendliness of prescriptive analytics software, making it accessible to a wider range of organizations. Additionally, the development of cloud-based solutions eliminates the need for hefty upfront infrastructure investments, further accelerating software adoption. This trend suggests a future where software becomes the dominant force in the Prescriptive Analytics Market.

On The Basis of Deployment:

The Prescriptive Analytics Market is divided by deployment model, with cloud and on-premise solutions vying for dominance. Cloud adoption is currently leading the charge, capturing around 65% of the market share. This dominance can be attributed to factors like scalability, cost-effectiveness, and ease of access. Cloud-based prescriptive analytics eliminates the need for expensive on-site infrastructure, allowing businesses to scale their operations effortlessly. However, on-premise solutions still hold a significant 35% share, particularly appealing to organizations with stringent data security concerns who prefer to maintain complete control over their data within their own data centers.

On The Basis of Business Function:

The Prescriptive Analytics Market caters to various business functions, with Operations leading the charge at 30% share. This focus on streamlining processes and optimizing resource allocation aligns perfectly with prescriptive analytics' ability to recommend optimal actions. Sales and Marketing follow closely at 25% and 20% share respectively, leveraging prescriptive analytics for targeted outreach, dynamic pricing, and lead nurturing. Finance, with a 15% share, utilizes prescriptive analytics for risk management, fraud detection, and investment optimization. Human Resources, at 10% share, is harnessing this technology for talent acquisition, skills gap analysis, and workforce planning.

KEY MARKET SEGMENTS:

On The Basis of Component:

  • Software

  • Services

On The Basis of Deployment:

  • CLOUD

  • ON-PREMISE

On The Basis of Business Function:

  • Operations

  • Sales

  • Marketing

  • Finance

  • Human Resources

On The Basis of Industry Vertical:

  • Healthcare

  • BFSI

  • IT & Telecommunications

  • Retail

  • Media & Entertainment

  • Manufacturing

  • Energy & Utilities

  • Transportation & Logistics

  • Government

  • Others

Prescriptive Analytics Market Segmentation Analysis

Need any customization research on Prescriptive analytics Market - Enquiry Now

REGIONAL ANALYSIS:

The Prescriptive Analytics Market is geographically diversified in terms of opportunity and growth, with North America currently holding the maximum share at around 55%. This dominance can be attributed to the region's well-developed IT infrastructure, fostering seamless data processing and integration for advanced analytics. Additionally, a culture of innovation and the presence of numerous industry titans like IBM and SAS further fuels market growth in North America. However, regions like Asia Pacific are expected to witness the fastest growth rate due to rapid digitalization and a growing pool of tech-savvy businesses. Government initiatives promoting AI adoption in countries like China and India will likely accelerate this trend, making the Prescriptive Analytics Market a global phenomenon.

REGIONAL COVERAGE:

North America

  • US

  • Canada

  • Mexico

Europe

  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of the Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America

KEY PLAYERS:

The major key players are Fair Isaac Corporation, International business machines corporation, Infor, Oracle Corporation, River Logic, inc., Salesforce.com, inc., Sap Se, SAS institute inc., Teradata corporation, Tibco software inc. & Other Players.

RECENT DEVELOPMENTS:

  • Microsoft, with their May 2022 launch of the Microsoft Intelligent Data Platform, are offering unified cloud-based solutions. This simplifies data management and allows businesses to focus on extracting insights

  • SAS, in May 2021, promoted its cloud-native SAS Viya platform with new data management solutions. This signifies the growing importance of robust data infrastructure for effective prescriptive analytics

  • Companies are forcing partnerships to expand their offerings. For example, IBM's Cloud Satellite, launched in March 2021, enables clients to leverage cloud services anywhere, potentially paving the way for broader adoption of prescriptive analytics solutions.

Teradata Corporation -Company Financial Analysis

Company Landscape Analysis

Prescriptive analytics Market Report Scope:
Report Attributes Details
Market Size in 2023  US$ 7.57 Bn
Market Size by 2031  US$ 43.14 Bn
CAGR   CAGR of 24.3% From 2024 to 2031
Base Year  2023
Forecast Period  2024-2031
Historical Data  2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • by Component (Software and Services)
• by Deployment (Cloud and on-premise)
• by Business Function (Operations, Sales, Marketing, Finance, Human Resources)
• by Application (Healthcare, BFSI, IT & Telecommunications, Retail, Media & Entertainment, Manufacturing, Energy & Utilities, Transportation & Logistics, Government, Others)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)
Company Profiles Fair Isaac Corporation, International business machines corporation, Infor, Oracle Corporation, River Logic, inc., Salesforce.com, inc., Sap Se, SAS institute inc., Teradata corporation, Tibco software inc.
Key Drivers • The industry of AI and machine learning is advancing at a breakneck pace
• Because of the rise in cyber-crime, there is a greater demand for crime prediction and prevention
Market Opportunities • Security breaches on the internet are causing alarm among enterprises all across the world, but they are also offering new opportunities

 

Frequently Asked Questions

Ans: - The estimated market size for the Prescriptive Analytics market for the year 2030 is USD 43.14 Bn.

Ans: - The industry of AI and machine learning is advancing at a breakneck pace and because of the rise in cyber-crime, there is a greater demand for crime prediction and prevention.

Ans: -The segments covered in the Prescriptive Analytics Market report for study are on the basis of component deployment, business function, and industry vertical.

Ans: - The major key players are Fair Isaac Corporation, International business machines corporation, Infor, Oracle Corporation, River Logic, inc., Salesforce.com, inc., Sap Se, SAS institute inc., Teradata corporation, Tibco software inc.

Ans: - Key Stakeholders Considered in the study are Raw material vendors, Regulatory authorities, including government agencies and NGOs, Commercial research, and development (R&D) institutions, Importers and exporters, etc.

TABLE OF CONTENTS

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

5. Impact Analysis

5.1 Impact of Russia-Ukraine Crisis

5.2 Impact of Economic Slowdown on Major Countries

5.2.1 Introduction

5.2.2 United States

5.2.3 Canada

5.2.4 Germany

5.2.5 France

5.2.6 UK

5.2.7 China

5.2.8 Japan

5.2.9 South Korea

5.2.10 India

6. Value Chain Analysis

7. Porter’s 5 Forces Model

8. Pest Analysis

9. Prescriptive Analytics Market Segmentation, by Component

9.1 Introduction

9.2 Trend Analysis

9.3 Software

9.4 Services

10. Prescriptive Analytics Market Segmentation, by deployment

10.1 Introduction

10.2 Trend Analysis

10.3 Cloud

10.4 On-Premise

11. Neuroendoscopy Market Segmentation, By Business Function

11.1 Introduction

11.2 Trend Analysis

11.3 Sales

11.4 Marketing

11.5 Finance

11.6 HR

12. Prescriptive Analytics Market Segmentation, by Industry Vertical

12.1 Introduction

12.2 Trend Analysis

12.3 Healthcare

12.4 BFSI

12.5 IT & Telecommunications

12.6 Retail

12.7 Media & Entertainment

12.8 Manufacturing

12.9 Energy & Utilities

12.10 Transportation & Logistics

12.11 Government

12.12 Others

13. Regional Analysis

13.1 Introduction

13.2 North America

13.2.1 Trend Analysis

13.2.2 North America Neuroendoscopy Market by Country

13.2.3 North America Neuroendoscopy Market By Component

13.2.4 North America Neuroendoscopy Market By Deployment

13.2.5 North America Neuroendoscopy Market By Business Function

13.2.6 North America Neuroendoscopy Market By Industry Vertical

13.2.7 USA

13.2.7.1 USA Neuroendoscopy Market By Component

13.2.7.2 USA Neuroendoscopy Market By Deployment

13.2.7.3 USA Neuroendoscopy Market By Business Function

13.2.7.4 USA Neuroendoscopy Market By Industry Vertical

13.2.8 Canada

13.2.8.1 Canada Neuroendoscopy Market By Component

13.2.8.2 Canada Neuroendoscopy Market By Deployment

13.2.8.3 Canada Neuroendoscopy Market By Business Function

13.2.8.4 Canada Neuroendoscopy Market By Industry Vertical

13.2.9 Mexico

13.2.9.1 Mexico Neuroendoscopy Market By Component

13.2.9.2 Mexico Neuroendoscopy Market By Deployment

13.2.9.3 Mexico Neuroendoscopy Market By Business Function

13.2.9.4 Mexico Neuroendoscopy Market By Industry Vertical

13.3 Europe

13.3.1 Trend Analysis

13.3.2 Eastern Europe

13.3.2.1 Eastern Europe Neuroendoscopy Market by Country

13.3.2.2 Eastern Europe Neuroendoscopy Market By Component

13.3.2.3 Eastern Europe Neuroendoscopy Market By Deployment

13.3.2.4 Eastern Europe Neuroendoscopy Market By Business Function

13.3.2.5 Eastern Europe Neuroendoscopy Market By Industry Vertical

13.3.2.6 Poland

13.3.2.6.1 Poland Neuroendoscopy Market By Component

13.3.2.6.2 Poland Neuroendoscopy Market By Deployment

13.3.2.6.3 Poland Neuroendoscopy Market By Business Function

13.3.2.6.4 Poland Neuroendoscopy Market By Industry Vertical

13.3.2.7 Romania

13.3.2.7.1 Romania Neuroendoscopy Market By Component

13.3.2.7.2 Romania Neuroendoscopy Market By Deployment

13.3.2.7.3 Romania Neuroendoscopy Market By Business Function

13.3.2.7.4 Romania Neuroendoscopy Market By Industry Vertical

13.3.2.8 Hungary

13.3.2.8.1 Hungary Neuroendoscopy Market By Component

13.3.2.8.2 Hungary Neuroendoscopy Market By Deployment

13.3.2.8.3 Hungary Neuroendoscopy Market By Business Function

13.3.2.8.4 Hungary Neuroendoscopy Market By Industry Vertical

13.3.2.9 Turkey

13.3.2.9.1 Turkey Neuroendoscopy Market By Component

13.3.2.9.2 Turkey Neuroendoscopy Market By Deployment

13.3.2.9.3 Turkey Neuroendoscopy Market By Business Function

13.3.2.9.4 Turkey Neuroendoscopy Market By Industry Vertical

13.3.2.10 Rest of Eastern Europe

13.3.2.10.1 Rest of Eastern Europe Neuroendoscopy Market By Component

13.3.2.10.2 Rest of Eastern Europe Neuroendoscopy Market By Deployment

13.3.2.10.3 Rest of Eastern Europe Neuroendoscopy Market By Business Function

13.3.2.10.4 Rest of Eastern Europe Neuroendoscopy Market By Industry Vertical

13.3.3 Western Europe

13.3.3.1 Western Europe Neuroendoscopy Market by Country

13.3.3.2 Western Europe Neuroendoscopy Market By Component

13.3.3.3 Western Europe Neuroendoscopy Market By Deployment

13.3.3.4 Western Europe Neuroendoscopy Market By Business Function

13.3.3.5 Western Europe Neuroendoscopy Market By Industry Vertical

13.3.3.6 Germany

13.3.3.6.1 Germany Neuroendoscopy Market By Component

13.3.3.6.2 Germany Neuroendoscopy Market By Deployment

13.3.3.6.3 Germany Neuroendoscopy Market By Business Function

13.3.3.6.4 Germany Neuroendoscopy Market By Industry Vertical

13.3.3.7 France

13.3.3.7.1 France Neuroendoscopy Market By Component

13.3.3.7.2 France Neuroendoscopy Market By Deployment

13.3.3.7.3 France Neuroendoscopy Market By Business Function

13.3.3.7.4 France Neuroendoscopy Market By Industry Vertical

13.3.3.8 UK

13.3.3.8.1 UK Neuroendoscopy Market By Component

13.3.3.8.2 UK Neuroendoscopy Market By Deployment

13.3.3.8.3 UK Neuroendoscopy Market By Business Function

13.3.3.8.4 UK Neuroendoscopy Market By Industry Vertical

13.3.3.9 Italy

13.3.3.9.1 Italy Neuroendoscopy Market By Component

13.3.3.9.2 Italy Neuroendoscopy Market By Deployment

13.3.3.9.3 Italy Neuroendoscopy Market By Business Function

13.3.3.9.4 Italy Neuroendoscopy Market By Industry Vertical

13.3.3.10 Spain

13.3.3.10.1 Spain Neuroendoscopy Market By Component

13.3.3.10.2 Spain Neuroendoscopy Market By Deployment

13.3.3.10.3 Spain Neuroendoscopy Market By Business Function

13.3.3.10.4 Spain Neuroendoscopy Market By Industry Vertical

13.3.3.11 Netherlands

13.3.3.11.1 Netherlands Neuroendoscopy Market By Component

13.3.3.11.2 Netherlands Neuroendoscopy Market By Deployment

13.3.3.11.3 Netherlands Neuroendoscopy Market By Business Function

13.3.3.11.4 Netherlands Neuroendoscopy Market By Industry Vertical

13.3.3.12 Switzerland

13.3.3.12.1 Switzerland Neuroendoscopy Market By Component

13.3.3.12.2 Switzerland Neuroendoscopy Market By Deployment

13.3.3.12.3 Switzerland Neuroendoscopy Market By Business Function

13.3.3.12.4 Switzerland Neuroendoscopy Market By Industry Vertical

13.3.3.13 Austria

13.3.3.13.1 Austria Neuroendoscopy Market By Component

13.3.3.13.2 Austria Neuroendoscopy Market By Deployment

13.3.3.13.3 Austria Neuroendoscopy Market By Business Function

13.3.3.13.4 Austria Neuroendoscopy Market By Industry Vertical

13.3.3.14 Rest of Western Europe

13.3.3.14.1 Rest of Western Europe Neuroendoscopy Market By Component

13.3.3.14.2 Rest of Western Europe Neuroendoscopy Market By Deployment

13.3.3.14.3 Rest of Western Europe Neuroendoscopy Market By Business Function

13.3.3.14.4 Rest of Western Europe Neuroendoscopy Market By Industry Vertical

13.4 Asia-Pacific

13.4.1 Trend Analysis

13.4.2 Asia-Pacific Neuroendoscopy Market by Country

13.4.3 Asia-Pacific Neuroendoscopy Market By Component

13.4.4 Asia-Pacific Neuroendoscopy Market By Deployment

13.4.5 Asia-Pacific Neuroendoscopy Market By Business Function

13.4.6 Asia-Pacific Neuroendoscopy Market By Industry Vertical

13.4.7 China

13.4.7.1 China Neuroendoscopy Market By Component

13.4.7.2 China Neuroendoscopy Market By Deployment

13.4.7.3 China Neuroendoscopy Market By Business Function

13.4.7.4 China Neuroendoscopy Market By Industry Vertical

13.4.8 India

13.4.8.1 India Neuroendoscopy Market By Component

13.4.8.2 India Neuroendoscopy Market By Deployment

13.4.8.3 India Neuroendoscopy Market By Business Function

13.4.8.4 India Neuroendoscopy Market By Industry Vertical

13.4.9 Japan

13.4.9.1 Japan Neuroendoscopy Market By Component

13.4.9.2 Japan Neuroendoscopy Market By Deployment

13.4.9.3 Japan Neuroendoscopy Market By Business Function

13.4.9.4 Japan Neuroendoscopy Market By Industry Vertical

13.4.10 South Korea

13.4.10.1 South Korea Neuroendoscopy Market By Component

13.4.10.2 South Korea Neuroendoscopy Market By Deployment

13.4.10.3 South Korea Neuroendoscopy Market By Business Function

13.4.10.4 South Korea Neuroendoscopy Market By Industry Vertical

13.4.11 Vietnam

13.4.11.1 Vietnam Neuroendoscopy Market By Component

13.4.11.2 Vietnam Neuroendoscopy Market By Deployment

13.4.11.3 Vietnam Neuroendoscopy Market By Business Function

13.4.11.4 Vietnam Neuroendoscopy Market By Industry Vertical

13.4.12 Singapore

13.4.12.1 Singapore Neuroendoscopy Market By Component

13.4.12.2 Singapore Neuroendoscopy Market By Deployment

13.4.12.3 Singapore Neuroendoscopy Market By Business Function

13.4.12.4 Singapore Neuroendoscopy Market By Industry Vertical

13.4.13 Australia

13.4.13.1 Australia Neuroendoscopy Market By Component

13.4.13.2 Australia Neuroendoscopy Market By Deployment

13.4.13.3 Australia Neuroendoscopy Market By Business Function

13.4.13.4 Australia Neuroendoscopy Market By Industry Vertical

13.4.14 Rest of Asia-Pacific

13.4.14.1 Rest of Asia-Pacific Neuroendoscopy Market By Component

13.4.14.2 Rest of Asia-Pacific Neuroendoscopy Market By Deployment

13.4.14.3 Rest of Asia-Pacific Neuroendoscopy Market By Business Function

13.4.14.4 Rest of Asia-Pacific Neuroendoscopy Market By Industry Vertical

13.5 Middle East & Africa

13.5.1 Trend Analysis

13.5.2 Middle East

13.5.2.1 Middle East Neuroendoscopy Market by Country

13.5.2.2 Middle East Neuroendoscopy Market By Component

13.5.2.3 Middle East Neuroendoscopy Market By Deployment

13.5.2.4 Middle East Neuroendoscopy Market By Business Function

13.5.2.5 Middle East Neuroendoscopy Market By Industry Vertical

13.5.2.6 UAE

13.5.2.6.1 UAE Neuroendoscopy Market By Component

13.5.2.6.2 UAE Neuroendoscopy Market By Deployment

13.5.2.6.3 UAE Neuroendoscopy Market By Business Function

13.5.2.6.4 UAE Neuroendoscopy Market By Industry Vertical

13.5.2.7 Egypt

13.5.2.7.1 Egypt Neuroendoscopy Market By Component

13.5.2.7.2 Egypt Neuroendoscopy Market By Deployment

13.5.2.7.3 Egypt Neuroendoscopy Market By Business Function

13.5.2.7.4 Egypt Neuroendoscopy Market By Industry Vertical

13.5.2.8 Saudi Arabia

13.5.2.8.1 Saudi Arabia Neuroendoscopy Market By Component

13.5.2.8.2 Saudi Arabia Neuroendoscopy Market By Deployment

13.5.2.8.3 Saudi Arabia Neuroendoscopy Market By Business Function

13.5.2.8.4 Saudi Arabia Neuroendoscopy Market By Industry Vertical

13.5.2.9 Qatar

13.5.2.9.1 Qatar Neuroendoscopy Market By Component

13.5.2.9.2 Qatar Neuroendoscopy Market By Deployment

13.5.2.9.3 Qatar Neuroendoscopy Market By Business Function

13.5.2.9.4 Qatar Neuroendoscopy Market By Industry Vertical

13.5.2.10 Rest of Middle East

13.5.2.10.1 Rest of Middle East Neuroendoscopy Market By Component

13.5.2.10.2 Rest of Middle East Neuroendoscopy Market By Deployment

13.5.2.10.3 Rest of Middle East Neuroendoscopy Market By Business Function

13.5.2.10.4 Rest of Middle East Neuroendoscopy Market By Industry Vertical

13.5.3 Africa

13.5.3.1 Africa Neuroendoscopy Market by Country

13.5.3.2 Africa Neuroendoscopy Market By Component

13.5.3.3 Africa Neuroendoscopy Market By Deployment

13.5.3.4 Africa Neuroendoscopy Market By Business Function

13.5.3.5 Africa Neuroendoscopy Market By Industry Vertical

13.5.3.6 Nigeria

13.5.3.6.1 Nigeria Neuroendoscopy Market By Component

13.5.3.6.2 Nigeria Neuroendoscopy Market By Deployment

13.5.3.6.3 Nigeria Neuroendoscopy Market By Business Function

13.5.3.6.4 Nigeria Neuroendoscopy Market By Industry Vertical

13.5.3.7 South Africa

13.5.3.7.1 South Africa Neuroendoscopy Market By Component

13.5.3.7.2 South Africa Neuroendoscopy Market By Deployment

13.5.3.7.3 South Africa Neuroendoscopy Market By Business Function

13.5.3.7.4 South Africa Neuroendoscopy Market By Industry Vertical

13.5.3.8 Rest of Africa

13.5.3.8.1 Rest of Africa Neuroendoscopy Market By Component

13.5.3.8.2 Rest of Africa Neuroendoscopy Market By Deployment

13.5.3.8.3 Rest of Africa Neuroendoscopy Market By Business Function

13.5.3.8.4 Rest of Africa Neuroendoscopy Market By Industry Vertical

13.6 Latin America

13.6.1 Trend Analysis

13.6.2 Latin America Neuroendoscopy Market by country

13.6.3 Latin America Neuroendoscopy Market By Component

13.6.4 Latin America Neuroendoscopy Market By Deployment

13.6.5 Latin America Neuroendoscopy Market By Business Function

13.6.6 Latin America Neuroendoscopy Market By Industry Vertical

13.6.7 Brazil

13.6.7.1 Brazil Neuroendoscopy Market By Component

13.6.7.2 Brazil Neuroendoscopy Market By Deployment

13.6.7.3 Brazil Neuroendoscopy Market By Business Function

13.6.7.4 Brazil Neuroendoscopy Market By Industry Vertical

13.6.8 Argentina

13.6.8.1 Argentina Neuroendoscopy Market By Component

13.6.8.2 Argentina Neuroendoscopy Market By Deployment

13.6.8.3 Argentina Neuroendoscopy Market By Business Function

13.6.8.4 Argentina Neuroendoscopy Market By Industry Vertical

13.6.9 Colombia

13.6.9.1 Colombia Neuroendoscopy Market By Component

13.6.9.2 Colombia Neuroendoscopy Market By Deployment

13.6.9.3 Colombia Neuroendoscopy Market By Business Function

13.6.9.4 Colombia Neuroendoscopy Market By Industry Vertical

13.6.10 Rest of Latin America

13.6.10.1 Rest of Latin America Neuroendoscopy Market By Component

13.6.10.2 Rest of Latin America Neuroendoscopy Market By Deployment

13.6.10.3 Rest of Latin America Neuroendoscopy Market By Business Function

13.6.10.4 Rest of Latin America Neuroendoscopy Market By Industry Vertical

14. Company Profiles

14.1 Fair Isaac Corporation

14.1.1 Company Overview

14.1.2 Financial

14.1.3 Products/ Services Offered

14.1.4 SWOT Analysis

14.1.5 The SNS View

14.2 International business machines corporation

14.2.1 Company Overview

14.2.2 Financial

14.2.3 Products/ Services Offered

14.2.4 SWOT Analysis

14.2.5 The SNS View

14.3 Infor

14.3.1 Company Overview

14.3.2 Financial

14.3.3 Products/ Services Offered

14.3.4 SWOT Analysis

14.3.5 The SNS View

14.4 Oracle Corporation

14.4.1 Company Overview

14.4.2 Financial

14.4.3 Products/ Services Offered

14.4.4 SWOT Analysis

14.4.5 The SNS View

14.5 River Logic, inc.

14.5.1 Company Overview

14.5.2 Financial

14.5.3 Products/ Services Offered

14.5.4 SWOT Analysis

14.5.5 The SNS View

14.6 Salesforce.com, inc.

14.6.1 Company Overview

14.6.2 Financial

14.6.3 Products/ Services Offered

14.6.4 SWOT Analysis

14.6.5 The SNS View

14.7 Sap Se.

14.7.1 Company Overview

14.7.2 Financial

14.7.3 Products/ Services Offered

14.7.4 SWOT Analysis

14.7.5 The SNS View

14.8 SAS institute inc.

14.8.1 Company Overview

14.8.2 Financial

14.8.3 Products/ Services Offered

14.8.4 SWOT Analysis

14.8.5 The SNS View

14.9 Teradata corporation

14.9.1 Company Overview

14.9.2 Financial

14.9.3 Products/ Services Offered

14.9.4 SWOT Analysis

14.9.5 The SNS View

14.10 Tibco software inc.

14.10.1 Company Overview

14.10.2 Financial

14.10.3 Products/ Services Offered

14.10.4 SWOT Analysis

14.10.5 The SNS View

 

15. Competitive Landscape

15.1 Competitive Benchmarking

15.2 Market Share Analysis

15.3 Recent Developments

15.3.1 Industry News

15.3.2 Company News

15.3.3 Mergers & Acquisitions

16. Use Case and Best Practices

17. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone